Sfikakis PP - Search Results

1

Early effects of IL-6 receptor inhibition on bone homeostasis: a pilot study in women with rheumatoid arthritis.

Terpos E, Fragiadaki K, Konsta M, Bratengeier C, Papatheodorou A, Sfikakis PP. Terpos E, et al. Among authors: sfikakis pp. Clin Exp Rheumatol. 2011 Nov-Dec;29(6):921-5. Epub 2011 Dec 22. Clin Exp Rheumatol. 2011. PMID: 22032557

2

Increased levels of intercellular adhesion molecule-1 in the serum of patients with systemic lupus erythematosus.

Sfikakis PP, Charalambopoulos D, Vayiopoulos G, Oglesby R, Sfikakis P, Tsokos GC. Sfikakis PP, et al. Among authors: sfikakis p. Clin Exp Rheumatol. 1994 Jan-Feb;12(1):5-9. Clin Exp Rheumatol. 1994. PMID: 7909280

3

Lymphocyte adhesion molecules in autoimmune rheumatic diseases: basic issues and clinical expectations.

Sfikakis PP, Tsokos GC. Sfikakis PP, et al. Clin Exp Rheumatol. 1995 Nov-Dec;13(6):763-77. Clin Exp Rheumatol. 1995. PMID: 8835253 Review.

4

Circulating P- and L-selectin and T-lymphocyte activation and patients with autoimmune rheumatic diseases.

Sfikakis PP, Charalambopoulos D, Vaiopoulos G, Mavrikakis M. Sfikakis PP, et al. Clin Rheumatol. 1999;18(1):28-32. doi: 10.1007/s100670050047. Clin Rheumatol. 1999. PMID: 10088945

5

Adhesion and lymphocyte costimulatory molecules in systemic rheumatic diseases.

Sfikakis PP, Mavrikakis M. Sfikakis PP, et al. Clin Rheumatol. 1999;18(4):317-27. doi: 10.1007/s100670050109. Clin Rheumatol. 1999. PMID: 10468173 Review.

6

Glucocorticoid effects on myocardial performance in patients with systemic sclerosis.

Antoniades L, Sfikakis PP, Mavrikakis M. Antoniades L, et al. Among authors: sfikakis pp. Clin Exp Rheumatol. 2001 Jul-Aug;19(4):431-7. Clin Exp Rheumatol. 2001. PMID: 11491499

7

Tumor necrosis factor biology in experimental and clinical arthritis.

Sfikakis PP, Kollias G. Sfikakis PP, et al. Curr Opin Rheumatol. 2003 Jul;15(4):380-6. doi: 10.1097/00002281-200307000-00003. Curr Opin Rheumatol. 2003. PMID: 12819464 Review.

8

Successful treatment of refractory adult-onset Still's disease with infliximab. A prospective, non-comparative series of four patients.

Kokkinos A, Iliopoulos A, Greka P, Efthymiou A, Katsilambros N, Sfikakis PP. Kokkinos A, et al. Among authors: sfikakis pp. Clin Rheumatol. 2004 Feb;23(1):45-9. doi: 10.1007/s10067-003-0775-5. Epub 2003 Nov 15. Clin Rheumatol. 2004. PMID: 14749983

9

Remission of proliferative lupus nephritis following B cell depletion therapy is preceded by down-regulation of the T cell costimulatory molecule CD40 ligand: an open-label trial.

Sfikakis PP, Boletis JN, Lionaki S, Vigklis V, Fragiadaki KG, Iniotaki A, Moutsopoulos HM. Sfikakis PP, et al. Arthritis Rheum. 2005 Feb;52(2):501-13. doi: 10.1002/art.20858. Arthritis Rheum. 2005. PMID: 15693003 Free article.

10

Increased expression of the FoxP3 functional marker of regulatory T cells following B cell depletion with rituximab in patients with lupus nephritis.

Sfikakis PP, Souliotis VL, Fragiadaki KG, Moutsopoulos HM, Boletis JN, Theofilopoulos AN. Sfikakis PP, et al. Clin Immunol. 2007 Apr;123(1):66-73. doi: 10.1016/j.clim.2006.12.006. Epub 2007 Jan 31. Clin Immunol. 2007. PMID: 17275413

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

613 results

Search Page

Filters